KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Asset Utilization Ratio (2016 - 2025)

Neogenomics (NEO) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.35 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 12.55% year-over-year to 0.35, compared with a TTM value of 0.35 through Dec 2025, down 12.55%, and an annual FY2025 reading of 0.49, up 21.91% over the prior year.
  • Asset Utilization Ratio was 0.35 for Q4 2025 at Neogenomics, up from 0.34 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.6 in Q1 2021 and bottomed at 0.25 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.35, with a median of 0.34 recorded in 2025.
  • The sharpest move saw Asset Utilization Ratio tumbled 71.59% in 2021, then rose 21.69% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.26 in 2021, then grew by 13.69% to 0.29 in 2022, then increased by 20.77% to 0.35 in 2023, then rose by 14.38% to 0.4 in 2024, then fell by 12.55% to 0.35 in 2025.
  • Business Quant data shows Asset Utilization Ratio for NEO at 0.35 in Q4 2025, 0.34 in Q3 2025, and 0.46 in Q2 2025.